Beneficial effects of atorvastatin on renal function in chronic kidney disease patients after primary percutaneous coronary intervention who were on rosuvastatin

被引：0
|
作者：
Sato, T. [1 ]
Kameyama, T. [2 ]
Inoue, H. [2 ]
机构：
[1] Itoigawa Gen Hosp, Itoigawa, Japan
[2] Toyama Univ, Toyama 930, Japan
来源：
EUROPEAN HEART JOURNAL | 2013年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1029 / 1029
页数：1
相关论文
共 50 条
  • [1] Influence of chronic kidney disease and worsening renal function on clinical outcomes in patients undergoing primary percutaneous coronary intervention
    Toshijiro Aoki
    Hideki Ishii
    Akihito Tanaka
    Susumu Suzuki
    Satoshi Ichimiya
    Masaaki Kanashiro
    Toyoaki Murohara
    Clinical and Experimental Nephrology, 2019, 23 : 182 - 188
  • [2] Influence of chronic kidney disease and worsening renal function on clinical outcomes in patients undergoing primary percutaneous coronary intervention
    Aoki, Toshijiro
    Ishii, Hideki
    Tanaka, Akihito
    Suzuki, Susumu
    Ichimiya, Satoshi
    Kanashiro, Masaaki
    Murohara, Toyoaki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (02) : 182 - 188
  • [3] COMPARISON OF THE EFFICACY OF ROSUVASTATIN VERSUS ATORVASTATIN IN PREVENTING CONTRAST INDUCED NEPHROPATHY IN PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Chen, Jiyan
    Tan, Ning
    Liu, Yong
    Liu, Yuan-Hui
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1631 - A1631
  • [4] COMPARISON OF THE EFFICACY OF ROSUVASTATIN VERSUS ATORVASTATIN IN PREVENTING CONTRAST INDUCED NEPHROPATHY IN PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Liua, Y. H.
    Liua, Y.
    Tana, N.
    Chena, J. Y.
    HEART, 2015, 101 : A35 - A35
  • [5] Percutaneous coronary intervention in chronic kidney disease patients
    Tadros, GM
    Herzog, CA
    JOURNAL OF NEPHROLOGY, 2004, 17 (03) : 364 - 368
  • [6] Effects on Serum Uric Acid by Difference of the Renal Protective Effects with Atorvastatin and Rosuvastatin in Chronic Kidney Disease Patients
    Kose, Eiji
    An, Taesong
    Kikkawa, Akihiko
    Matsumoto, Yoshiaki
    Hayashi, Hiroyuki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2014, 37 (02) : 226 - 231
  • [7] Rosuvastatin and atorvastatin preserve renal function in HIV-1-infected patients with chronic kidney disease and hyperlipidaemia
    Calza, Leonardo
    Colangeli, Vincenzo
    Borderi, Marco
    Manfredi, Roberto
    Marconi, Lorenzo
    Bon, Isabella
    Re, Maria Carla
    Viale, Pierluigi
    HIV CLINICAL TRIALS, 2018, 19 (03): : 120 - 128
  • [8] Trajectory of renal function change and kidney injury after percutaneous coronary intervention in patients with stable coronary artery disease
    Yuki Deguchi
    Yuichi Saito
    Motohiro Nakao
    Hirokazu Shiraishi
    Naoya Sakamoto
    Satoru Kobayashi
    Yoshio Kobayashi
    Heart and Vessels, 2021, 36 : 315 - 320
  • [9] Trajectory of renal function change and kidney injury after percutaneous coronary intervention in patients with stable coronary artery disease
    Deguchi, Yuki
    Saito, Yuichi
    Nakao, Motohiro
    Shiraishi, Hirokazu
    Sakamoto, Naoya
    Kobayashi, Satoru
    Kobayashi, Yoshio
    HEART AND VESSELS, 2021, 36 (03) : 315 - 320
  • [10] Comparison of the Efficacy of Rosuvastatin versus Atorvastatin in Preventing Contrast Induced Nephropathy in Patient with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention
    Liu, Yong
    Liu, Yuan-hui
    Tan, Ning
    Chen, Ji-yan
    Zhou, Ying-ling
    Li, Li-wen
    Duan, Chong-yang
    Chen, Ping-Yan
    Luo, Jian-fang
    Li, Hua-long
    Wei-Guo
    PLOS ONE, 2014, 9 (10):
12345